←Back to Expert Scholars
Translational Medicine / 转化医学X-Inactivation Skewing, Clonal Hematopoiesis
Lambert Busque
MD, FRCPC
🏢Hopital Maisonneuve-Rosemont, Universite de Montreal🌐Canada
Hematologist and Professor
50
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Lambert Busque performed early work defining skewed X-inactivation as a marker of clonal hematopoiesis in aging women, well before the CHIP era. He later linked TET2 mutations to age-related clonal expansion. He continues to investigate genetic and epigenetic drivers of clonal hematopoiesis.
Share:
🧪Research Fields 研究领域
clonal hematopoiesis
X-inactivation
aging hematopoiesis
TET2
hematologic disease
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Lambert Busque 的研究动态
Follow Lambert Busque's research updates
留下邮箱，当我们发布与 Lambert Busque（Hopital Maisonneuve-Rosemont, Universite de Montreal）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment